BrainsWay Ltd. (BWAY)
NASDAQ: BWAY · Real-Time Price · USD
19.02
+0.04 (0.21%)
At close: Dec 31, 2025, 4:00 PM EST
19.08
+0.06 (0.32%)
After-hours: Dec 31, 2025, 4:10 PM EST
BrainsWay Market Cap
BrainsWay has a market cap or net worth of $376.99 million as of December 31, 2025. Its market cap has increased by 104.60% in one year.
Market Cap
376.99M
Enterprise Value
310.78M
1-Year Change
104.60%
Ranking
Category
Stock Price
$19.02
Market Cap Chart
Since September 3, 2013, BrainsWay's market cap has increased from $178.92M to $376.99M, an increase of 110.70%. That is a compound annual growth rate of 6.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 1, 2026 | 376.99M | -1.72% |
| Dec 31, 2025 | 383.61M | 112.68% |
| Dec 31, 2024 | 180.37M | 70.88% |
| Dec 31, 2023 | 105.55M | 216.46% |
| Dec 29, 2022 | 33.35M | -73.96% |
| Dec 30, 2021 | 128.06M | 62.02% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.25B |
| Johnson & Johnson | 498.60B |
| AbbVie | 403.83B |
| UnitedHealth Group | 299.03B |
| AstraZeneca | 287.81B |
| Novartis AG | 266.00B |
| Merck & Co. | 261.26B |
| Novo Nordisk | 227.63B |